5-Year Follow-Up Supports Curative Potential of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma (ZUMA-1)

Sattva S. Neelapu, Caron A. Jacobson, Armin Ghobadi, David B Miklos, Lazaros J. Lekakis, Olalekan O. Oluwole, Yi Lin, Ira Braunschweig, Brian T. Hill, John M. Timmerman, Abhinav Deol, Patrick M Reagan, Patrick Joseph Stiff, Ian W. Flinn, Umar Farooq, Andre Goy, Peter McSweeney, Javier Munoz, Tanya Siddiqi, Julio C. Chavez, Alex F. Herrera, Nancy L. Bartlett, Adrian A. Bot, Rhine R. Shen, Jinghui Dong, Kanwarjit Singh, Harry Miao, Jenny J. Kim, Yan Zheng, Frederick L. Locke

Open source

DOI: 10.1182/blood.2022018893
Published: 2023-02-23
Container: Blood
Publisher: American Society of Hematology
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2022018893,
  title = {5-Year Follow-Up Supports Curative Potential of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma (ZUMA-1)},
  author = {Sattva S. Neelapu and Caron A. Jacobson and Armin Ghobadi and David B Miklos and Lazaros J. Lekakis and Olalekan O. Oluwole and Yi Lin and Ira Braunschweig and Brian T. Hill and John M. Timmerman and Abhinav Deol and Patrick M Reagan and Patrick Joseph Stiff and Ian W. Flinn and Umar Farooq and Andre Goy and Peter McSweeney and Javier Munoz and Tanya Siddiqi and Julio C. Chavez and Alex F. Herrera and Nancy L. Bartlett and Adrian A. Bot and Rhine R. Shen and Jinghui Dong and Kanwarjit Singh and Harry Miao and Jenny J. Kim and Yan Zheng and Frederick L. Locke},
  year = {2023},
  journal = {Blood},
  doi = {10.1182/blood.2022018893},
  url = {https://doi.org/10.1182/blood.2022018893}
}

RIS

TY  - JOUR
TI  - 5-Year Follow-Up Supports Curative Potential of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma (ZUMA-1)
AU  - Sattva S. Neelapu
AU  - Caron A. Jacobson
AU  - Armin Ghobadi
AU  - David B Miklos
AU  - Lazaros J. Lekakis
AU  - Olalekan O. Oluwole
AU  - Yi Lin
AU  - Ira Braunschweig
AU  - Brian T. Hill
AU  - John M. Timmerman
AU  - Abhinav Deol
AU  - Patrick M Reagan
AU  - Patrick Joseph Stiff
AU  - Ian W. Flinn
AU  - Umar Farooq
AU  - Andre Goy
AU  - Peter McSweeney
AU  - Javier Munoz
AU  - Tanya Siddiqi
AU  - Julio C. Chavez
AU  - Alex F. Herrera
AU  - Nancy L. Bartlett
AU  - Adrian A. Bot
AU  - Rhine R. Shen
AU  - Jinghui Dong
AU  - Kanwarjit Singh
AU  - Harry Miao
AU  - Jenny J. Kim
AU  - Yan Zheng
AU  - Frederick L. Locke
PY  - 2023
JO  - Blood
DO  - 10.1182/blood.2022018893
UR  - https://doi.org/10.1182/blood.2022018893
ER  -

APA

Neelapu, S. S., Jacobson, C. A., Ghobadi, A., Miklos, D. B., Lekakis, L. J., Oluwole, O. O., Lin, Y., Braunschweig, I., Hill, B. T., Timmerman, J. M., Deol, A., Reagan, P. M., Stiff, P. J., Flinn, I. W., Farooq, U., Goy, A., McSweeney, P., Munoz, J., Siddiqi, T., Chavez, J. C., Herrera, A. F., Bartlett, N. L., Bot, A. A., Shen, R. R., Dong, J., Singh, K., Miao, H., Kim, J. J., Zheng, Y., & Locke, F. L. (2023). 5-Year Follow-Up Supports Curative Potential of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma (ZUMA-1). Blood. https://doi.org/10.1182/blood.2022018893

Source records

crossref · retrieved 2026-09-26T23:30:34.596Z